JUST IN
You are here » Home » Companies » Company Overview » Natco Pharma Ltd

Natco Pharma Ltd.

BSE: 524816 Sector: Health care
NSE: NATCOPHARM ISIN Code: INE987B01026
BSE 00:00 | 24 Apr 2020 Natco Pharma Ltd is not traded on BSE in the last 30 days
NSE 05:30 | 01 Jan 1970 Natco Pharma Ltd is not traded on NSE in the last 30 days

Notice: Undefined property: stdClass::$market_capital_for_nse in /usr2/unibs/application/modules/live-market/views/scripts/company/bs-new-bse-nse-block.php on line 17
Add to Watchlist  |   Add to Portfolio
OPEN 612.00
PREVIOUS CLOSE 617.20
VOLUME 24402
52-Week high 737.80
52-Week low 450.00
P/E 22.88
Mkt Cap.(Rs cr) 11,366
Buy Price 624.35
Buy Qty 54.00
Sell Price 628.95
Sell Qty 2.00
OPEN 612.00
CLOSE 617.20
VOLUME 24402
52-Week high 737.80
52-Week low 450.00
P/E 22.88
Mkt Cap.(Rs cr) 11,366
Buy Price 624.35
Buy Qty 54.00
Sell Price 628.95
Sell Qty 2.00

About Natco Pharma Ltd.

Natco Pharma Ltd

Natco Pharma Limited is a vertically integrated and R&D focused pharmaceutical company engaged in developing manufacturing and marketing of finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs). The company's focus is primarily on niche therapeutic areas and complex products. The company sells its products in over 40 countries. FDF products are sold in the United States I...> More

Natco Pharma Ltd - Key Fundamentals

Parameter Values
Market Cap ( cr)   11,366
EPS - TTM () [*S] 27.29
P/E Ratio (X) [*S] 22.88
Face Value ()   2
Latest Dividend (%)   175.00
Latest Dividend Date 24 Feb 2020
Dividend Yield (%) 1.01
Book Value / Share () [*S] 206.52
P/B Ratio () [*S] 3.02
[*C] Consolidated     [*S] Standalone    

Announcement

Natco Pharma Ltd - Financial Results

Particulars ( cr) Dec 2019 Dec 2018 % Chg
Net Sales 482.2 556.7 -13.38
Other Income 30.8 23.3 32.19
Total Income 513 580 -11.55
Total Expenses 353.5 348.3 1.49
Operating Profit 159.5 231.7 -31.16
Net Profit 104.4 159.3 -34.46
Equity Capital 36.4 36.8 -
> More on Natco Pharma Ltd Financials Results

Natco Pharma Ltd - Peer Group

Company Price() Chg (%) Mkt Cap ( CR)
Alembic Pharma 759.35 8.70 14313.75
Ajanta Pharma 1444.55 8.77 12603.70
Syngene Intl. 306.70 -2.12 12268.00
Natco Pharma 624.35 1.16 11366.29
Glenmark Pharma. 345.05 1.44 9737.31
Astrazeneca Phar 2777.50 7.33 6943.75
Proc. Gam. Heal. 4159.20 -0.05 6904.27
> More on Natco Pharma Ltd Peer Group

Natco Pharma Ltd - SHAREHOLDING PATTERN

Category Share (%)
Promoters 48.93
Banks/FIs 1.06
FIIs 21.67
Insurance 0.00
Mutual Funds 8.50
Indian Public 14.96
Custodians 0.00
Other 3.87
> More on Natco Pharma Ltd Share Holding Pattern

Natco Pharma Ltd - Research Reports

Date Broker Action Price Report
14/11 Anand Rathi Buy 561 PDF IconDetails
13/08 Anand Rathi Buy 552 PDF IconDetails
> More on Natco Pharma Ltd Research Reports

Natco Pharma Ltd - RETURNS

Period BSE NSE Sensex NIFTY
1 Week 1.30% 1.43% -0.83% -1.21%
1 Month 32.63% 32.58% 17.44% 17.35%
3 Month -5.42% -5.35% -24.72% -25.26%
6 Month 6.91% 6.88% -19.72% -20.96%
1 Year 15.59% 15.71% -19.79% -21.93%
3 Year -32.64% -32.48% 5.64% -0.69%

Natco Pharma Ltd - STOCK STRENGTH

Today's Low/High 609.15
642.00
Week Low/High 596.95
643.00
Month Low/High 450.00
650.00
YEAR Low/High 450.00
738.00
All TIME Low/High 1.60
1080.00

Browse STOCK Companies

Quick Links for Natco Pharma: